A detailed history of Cresset Asset Management, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 78,910 shares of PACB stock, worth $102,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,910
Previous 63,222 24.81%
Holding current value
$102,583
Previous $620,000 52.42%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $55,221 - $150,447
15,688 Added 24.81%
78,910 $295,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $36,733 - $63,745
6,153 Added 10.78%
63,222 $620,000
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $50,408 - $85,321
6,125 Added 12.02%
57,069 $476,000
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $507,911 - $715,763
50,944 New
50,944 $677,000
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $1,332 - $2,905
-339 Reduced 0.7%
48,405 $281,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $2,761 - $7,165
687 Added 1.43%
48,744 $214,000
Q1 2022

May 16, 2022

SELL
$8.43 - $20.9 $24,716 - $61,278
-2,932 Reduced 5.75%
48,057 $437,000
Q4 2021

Feb 10, 2022

SELL
$19.26 - $30.08 $310,432 - $484,829
-16,118 Reduced 24.02%
50,989 $1.04 Million
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $6,215 - $8,755
250 Added 0.37%
67,107 $1.72 Million
Q2 2021

Aug 10, 2021

BUY
$22.3 - $36.02 $11,685 - $18,874
524 Added 0.79%
66,857 $2.34 Million
Q1 2021

May 12, 2021

BUY
$26.38 - $51.15 $1.75 Million - $3.39 Million
66,333 New
66,333 $2.21 Million
Q4 2020

Feb 11, 2021

SELL
$10.5 - $28.5 $336,000 - $912,000
-32,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$3.61 - $9.87 $115,520 - $315,840
32,000 New
32,000 $316,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $292M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.